echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > Chemical Technology > Issue 20, 2012 - Pfizer and BYU reach settlement over Celebrex litigation

    Issue 20, 2012 - Pfizer and BYU reach settlement over Celebrex litigation

    • Last Update: 2022-11-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Pfizer and Brigham Young University (BYU) filed a six-year lawsuit against cyclooxygenase-2, the active ingredient in Pfizer's painkiller Celebrex, filed by BYU and Daniel L.
    Simmon
    , a chemistry professor at the university.

    Although the incident was not made public, Pfizer recorded $450 million in charges
    related to the settlement in its first-quarter financial statements.
    Previously, BYU offered to claim 15% of Celebrau's sales from the beginning to date as a royalty, which is close to $10 billion
    .

    As part of the solution, BYU will establish the Dan Simmons Forum to recognize Simmons' life's work and contributions
    to advancing human health in areas such as oncology and Alzheimer's.
    BYU was pleased with the settlement, which Simmons did not comment
    .
    (Li Wei)



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.